XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-based Compensation and Other Stock Plans - (Tables)
3 Months Ended
Apr. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted-Average Assumptions of Fair Value Granted Using Black-Scholes Valuation Model
The following weighted-average assumptions were used in calculating the fair value of stock options granted during three month periods ended April 1, 2023, and April 2, 2022, using the Black-Scholes valuation model:

Three Months Ended
April 1, 2023April 2, 2022
Expected term of option (in years)
4.905.14
Expected volatility factor23.99%22.61%
Expected dividend yield2.60%2.68%
Risk-free interest rate3.99%2.00%
Schedule of Stock Option Activity
A summary of stock option activity as of and for the three months ended April 1, 2023, is presented below:

Shares
(in thousands)
Exercise
Price Per
Share*
Remaining
Contractual
Term*
(in years)
Aggregate
Intrinsic
Value
(in millions)
Outstanding at December 31, 20222,349 $163.07 
Granted241 249.26 
Exercised(220)148.72 
Forfeited or expired(7)203.98 
Outstanding at April 1, 20232,363 173.08 5.8$175.0 
Exercisable at April 1, 20231,839 158.34 4.8162.8 
*Weighted-average
Schedule of Changes in Non-Vested Performance Awards
Changes to the company’s non-vested PSUs during the three months ended April 1, 2023, are as follows:
Shares
(in thousands)
Fair Value
Price per
Share*
Non-vested PSUs at December 31, 2022199 $196.51 
Granted58 249.26 
Performance assumption change **12 211.67 
Vested— — 
Cancellations and other(2)204.00 
Non-vested PSUs at April 1, 2023267 208.62 
*Weighted-average
**Reflects the number of PSUs above target levels based on performance metrics.
Schedule of Non-vested Restricted Stock Units Activity
Changes to the company’s non-vested RSUs during the three months ended April 1, 2023, are as follows:
Shares
(in thousands)
Fair Value
Price per
Share*
Non-vested RSUs at December 31, 202258 $200.16 
Granted26 249.26 
Vested— — 
Cancellations and other(1)203.64 
Non-vested RSUs at April 1, 202383 215.54 
*Weighted-average
Schedule of Weighted-Average Assumptions of Fair Value Granted Using Black-Scholes Valuation Model
The following weighted-average assumptions were used in calculating the fair value of stock-settled SARs granted during the three months ended April 1, 2023, and April 2, 2022, using the Black-Scholes valuation model:
 Three Months Ended
 April 1, 2023April 2, 2022
Expected term of stock-settled SARs (in years)
4.084.02
Expected volatility factor24.68%23.09%
Expected dividend yield2.60%2.68%
Risk-free interest rate3.87%1.96%
The following weighted-average assumptions were used in calculating the fair value of cash-settled SARs granted during the three months ended April 1, 2023, and April 2, 2022, using the Black-Scholes valuation model:
Three Months Ended
April 1, 2023April 2, 2022
Expected term of cash-settled SARs (in years)
3.963.88
Expected volatility factor24.42%23.09%
Expected dividend yield2.62%2.79%
Risk-free interest rate3.60%2.58%
Schedule of Changes in SARs
A summary of stock-settled SARs as of and for the three months ended April 1, 2023, are as follows:
Stock-settled
SARs
(in thousands)
Exercise
Price Per
Share*
Remaining
Contractual
Term*
(in years)
Aggregate
Intrinsic
Value
(in millions)
Outstanding at December 31, 2022385 $170.11 
Granted62 249.26 
Exercised(23)153.93 
Forfeited or expired(37)159.87 
Outstanding at April 1, 2023387 184.66 6.8$24.3 
Exercisable at April 1, 2023255 163.58 5.621.2 
*Weighted-average
Changes to the company’s non-vested cash-settled SARs during the three months ended April 1, 2023, are as follows:
Cash-settled
SARs
(in thousands)
Fair Value
Price per
Share*
Non-vested cash-settled SARs at December 31, 2022$53.24 
Granted48.85 
Vested(1)72.11 
Non-vested cash-settled SARs at April 1, 202354.52 
*Weighted-average